Vyriad

Novartis taps Vyriad’s viral vectors to develop in vivo T cell editing
Fierce Biotech
Wed, 11/20/24 - 08:44 pm
Novartis
Vyriad
viral vectors
t cell therapy
CAR-T
Biotech firm to build $9 million plant at IBM site
Post Bulletin, MN
Fri, 05/11/18 - 09:58 am
Vyriad
cancer vaccines
drug manufacturing